Irbesartan and Levothroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Irbesartan (irbesartan) and Levothroid (levothyroxine sodium). Common drug interactions include asthma among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Irbesartan and Levothroid. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

On Jul, 11, 2026

17 people who take Irbesartan and Levothroid together, and have interactions are studied.

Irbesartan and Levothroid drug interactions.

What are the common drug interactions of Irbesartan and Levothroid, by gender? *:

female:

Asthma
Hepatic enzyme increased
Hypersensitivity
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Acute myocardial infarction (acute heart attack)
Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Back pain
Blood cholesterol increased
Bone pain
Bone spur (bony growth)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Dyspnoea (difficult or laboured respiration)
Faeces discoloured
Hyperchlorhydria (gastric acid levels are higher in stomach)
Hypotension (abnormally low blood pressure)
Pulmonary embolism (blockage of the main artery of the lung)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Weight increased
Abdominal distension

What are the common drug interactions of Irbesartan and Levothroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Asthma
Hypersensitivity

50-59:

Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Cellulitis (infection under the skin)
Infection
Road traffic accident
Syncope (loss of consciousness with an inability to maintain postural tone)
Synovial fluid white blood cells positive

60+:

Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Bone spur (bony growth)
Cardiac failure congestive
Cough
Deafness
Drug ineffective
Dry skin
Ear pain
Electrocardiogram poor r-wave progression

What are the existing conditions these people have? *

Cardiac Disorder: 3 people, 17.65%
Blood Magnesium Decreased: 2 people, 11.76%
Blood Pressure Abnormal: 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Diabetes: 2 people, 11.76%
Neuropathy Peripheral (surface nerve damage): 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Insomnia (sleeplessness): 1 person, 5.88%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.88%
Gastric Disorder (disease of stomach): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and Levothroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously